【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 15
1.2 List of Figures 21
2 Introduction 22
2.1 Catalyst 22
2.2 Related Reports 22
2.3 Upcoming Related Reports 23
3 Disease Overview 24
3.1 Etiology and Pathophysiology 24
3.1.1 Etiology 24
3.1.2 Pathophysiology 25
3.2 Symptoms 28
4 Epidemiology 30
4.1 Disease Background 30
4.2 Risk Factors and Comorbidities 30
4.3 Global Trends 31
4.3.1 Prevalence 31
4.4 Forecast Methodology 33
4.4.1 Sources Used for One-Year Diagnosed Prevalence of Psoriasis 35
4.4.2 Sources Not Used 37
4.4.3 Forecast Assumptions and Methods, One-Year Diagnosed Prevalent Cases of Psoriasis 38
4.5 Epidemiological Forecast for Psoriasis (2014-2024) 40
4.5.1 One-Year Diagnosed Prevalent Cases of Psoriasis 40
4.5.2 Age-Specific One-Year Diagnosed Prevalent Cases of Psoriasis 42
4.5.3 Sex-Specific One-Year Diagnosed Prevalent Cases of Psoriasis 44
4.5.4 Age-Standardized One-Year Diagnosed Prevalent Cases of Psoriasis 46
4.5.5 One-Year Diagnosed Prevalent Cases of Psoriasis by Severity 47
4.6 Discussion 48
4.6.1 Epidemiological Forecast Insight 48
4.6.2 Limitations of the Analysis 49
4.6.3 Strengths of the Analysis 49
5 Disease Management 50
5.1 Diagnosis and Treatment Overview 50
5.1.1 Diagnosis 50
5.1.2 Leading Prescribed Drugs and Treatment Guidelines 51
5.1.3 Clinical Practice 54
5.2 US 54
5.3 5EU 59
5.4 Japan 62
5.5 India 65
6 Competitive Assessment 67
6.1 Overview 67
6.2 Strategic Competitor Assessment 68
6.3 Product Profiles – Major Brands 69
6.3.1 Enbrel (Etanercept) 69
6.3.2 Humira (Adalimumab) 76
6.3.3 Remicade (Infliximab) 82
6.3.4 Stelara (Ustekinumab) 89
6.3.5 Cosentyx (Secukinumab) 95
6.3.6 Taltz (Ixekizumab) 103
6.3.7 Otezla (Apremilast) 112
6.3.8 Taclonex and Enstilar (Calcipotriene and Betamethasone Dipropionate) 117
6.3.9 Methotrexate 123
6.3.10 Fumaderm (Fumaric Acid Esters) 128
6.3.11 Alzumab (Itolizumab) 133
6.3.12 Other Therapeutic Drug Classes Used in Psoriasis 136
6.3.13 Non-pharmacological Therapy 137
7 Unmet Need and Opportunity 140
7.1 Overview 140
7.2 Limited Patient Access Due to Drug Reimbursement Pattern 140
7.2.1 Unmet Need 140
7.2.2 Gap Analysis 141
7.2.3 Opportunity 142
7.3 Improved Drug Safety and Efficacy Profiles 142
7.3.1 Unmet Need 142
7.3.2 Gap Analysis 143
7.3.3 Opportunity 143
7.4 Education and Treatment of Psychological Factors Accompanying Psoriasis 144
7.4.1 Unmet Need 144
7.4.2 Gap Analysis 145
7.4.3 Opportunity 145
7.5 Physician Education About the Different Types of Psoriasis, not Just Plaque Psoriasis 146
7.5.1 Unmet Need 146
7.5.2 Gap Analysis 146
7.5.3 Opportunity 147
8 Pipeline Assessment 148
8.1 Overview 148
8.2 Clinical Trial Mapping 149
8.2.1 Clinical Trials by Country 149
8.3 Clinical Trials by Phase and Trial Status 150
8.4 Promising Drugs in Clinical Development 151
8.4.1 Xeljanz (Tofacitinib) 153
8.4.2 Brodalumab 160
8.4.3 Guselkumab (CNTO-1959) 168
8.4.4 Tildrakizumab 173
8.4.5 Piclidenoson (CF-101) 180
8.4.6 Additional Phase III Pipeline Products 185
8.4.7 Phase II Pipeline Products 185
8.4.8 Phase I Pipeline Products 187
8.5 Biosimilar Pipeline Products 188
8.5.1 Introduction 188
8.5.2 Hospira’s Inflectra Versus J&J’s Remicade in Key Autoimmune Diseases 189
8.5.3 Biosimilars in the Immunology Community 189
8.5.4 By the Numbers: Biosimilars in Development 190
8.5.5 The Impact of Biosimilars Will be Felt Throughout the Pharmaceutical Industry 194
8.5.6 Uptake of Biosimilars for Psoriasis is Expected to Vary by Market 195
8.5.7 Biosimilars Forecast 197
9 Current and Future Players 202
9.1 Overview 202
9.2 Trends in Corporate Strategy 205
9.3 Company Profiles 207
9.3.1 Johnson & Johnson 207
9.3.2 AbbVie 209
9.3.3 Amgen 211
9.3.4 Novartis 213
9.3.5 Pfizer 216
9.3.6 Eli Lilly 217
9.3.7 Merck 219
9.3.8 LEO Pharma 221
9.3.9 Celgene 224
9.3.10 Can-Fite Biopharma 225
10 Market Outlook 228
10.1 Global Markets 228
10.1.1 Forecast 228
10.1.2 Drivers and Barriers – Global Issues 233
10.2 US 236
10.2.1 Forecast 236
10.2.2 Key Events 242
10.2.3 Drivers and Barriers 242
10.3 5EU 244
10.3.1 Forecast 244
10.3.2 Key Events 250
10.3.3 Drivers and Barriers 250
10.4 Japan 252
10.4.1 Forecast 252
10.4.2 Key Events 256
10.4.3 Drivers and Barriers 256
10.5 India 258
10.5.1 Forecast 258
10.5.2 Key Events 261
10.5.3 Drivers and Barriers 261
11 Appendix 264
11.1 Bibliography 264
11.2 Abbreviations 281
11.3 Methodology 286
11.4 Forecasting Methodology 286
11.4.1 Diagnosed Psoriasis Patients 286
11.4.2 Percent Drug-Treated Patients 287
11.4.3 Drugs Included in Each Therapeutic Class 287
11.4.4 Launch and Patent Expiry Dates 288
11.4.5 General Pricing Assumptions 289
11.4.6 Individual Drug Assumptions 290
11.4.7 Generic Erosion 298
11.4.8 Pricing of Pipeline agents 298
11.5 Physicians and Specialists Included in this Study 299
11.6 Primary Research – Prescriber Survey 302
11.7 About the Authors 303
11.7.1 Author 303
11.7.2 Reviewer 303
11.7.3 Epidemiologist 304
11.7.4 Global Director of Therapy Analysis and Epidemiology 304
11.7.5 Global Head of Healthcare 305
11.8 About GlobalData 306
11.9 Disclaimer 306
【レポート販売概要】
■ タイトル：乾癬治療薬の世界市場予測・分析■ 英文：PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024
■ 発行日：2016年4月13日
■ 調査会社：GlobalData
■ 商品コード：GDHC119PIDR
■ 調査対象地域：グローバル
- 世界の太陽光封入市場：EVA、PVB、PDMS、イオノマー、TPU、ポリオレフィンGrowing demand of solar PVs and other applications with increasing investment in modernization of infrastructure will drive the global solar encapsulation market to 1,357.2 million by 2018, with a CAGR of 10.2% from 2013 to 2018. Asia, with its thriving economies and rapidly expanding manufacturing bases, is expected to experience highest revenue growth during the next five years. The factors driv …
- ランタイムアプリケーションセルフプロテクション（RASP）セキュリティの世界市場2016-2020About RASP Runtime application self-protection (RASP) protects the network applications from within, as it is integrated along with the application, both during production and during runtime. RASP transforms or blocks malicious content, database queries, and token activity depending on the nature of the implementation. The capabilities of RASP such as coverage, performance, integration, and real-t …
- ガソリン計量機の世界市場2017-2021About Fuel Dispensers The global fuel dispenser market has been witnessing substantial growth in recent years, mainly due to the growth of the automotive industry in various regions. The growing per capita disposable incomes of consumers has also had a positive impact on the overall demand for fuel, as the fuel consumption rate has increased. Many consumers are buying multiple cars, which is leadi …
- ヘルスケア支払人BPOの世界市場の規模･分析：サービス別（クレーム処理サービス、会員サービス、人事サービス、財務および会計）、動向分析、セグメント予測、2012-2022Global healthcare payer BPO market is expected to reach over USD 34.2 billion by 2022 according to a new report by Grand View Research Inc. Key drivers attributing to the growth are ObamaCare, shift to ICD-10 coding system, growing geriatric population, increasing disease burden and penetration of insurance coverage in emerging economies. In 2013, as per estimates published by the America’s Health …
- Pompe Disease：グローバル臨床試験レビューH2, 2013Pompe Disease Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, H2, 2013" provides data on the Pompe Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pompe Disease. It includes an overview of the trial numbers and their recruitment status as per the …
- ミッドキャップバイオテクノロジー企業ベンチマークレポートPharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report - Financial Benchmarking, Pipeline Assessment & Competitive Analysis of Innovative Biotechs Summary The Innovative Mid-Cap Biotech Benchmark Report applies GlobalData’s proprietary ranking methodology to compare the competitive position of 15 innovative biotech companies on 20 financial metrics. The performances of these companies ar …
- マネージド型セキュリティサービスの世界市場2016-2020About Managed Security Services Managed security services are the services provided by an outsourced managed security service provider to maintain information security and network security. This service is provided either on the client's premises or it is outsourced to a company that specializes in networking and information system security. Managed security service providers (MSSPs) offer managed …
- Apokyn (パーキンソン病)：医薬品市場予測及び分析（～2022）Apokyn (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural instability. As the second most common neurodegenerative disorder, Parkinson’s disease may affect individuals of any age but prevalence is increased with age and it is most common in the elderly. Do …
- 心臓血管情報システム（CVIS）の世界市場：カテーテル検査室、ECGデータ管理、心エコー検査室、血管検査室用途About Cardiovascular Information System A CVIS is a collection of research and clinical data gathered with the help of unique software, which facilitates information and support, and provides a complete medical record of patients in the cardiovascular field. The CVIS is used to endorse data with a high level of evidence-based quality. The CVIS improves patient safety and provides quality care by e …
- 送配電用ケーブルのグローバル市場動向Due to the impact of the economic slowdown, the market witnessed a decline in the growth rate from 2009. However, the market is set to achieve strong growth rate from 2012 onwards. Capital spending and investments in industries worldwide is expected to boost growth of the market. The economic recession had its effect on the transmission and distribution sector, and due to the ongoing financial cri …
- 静脈照射器の世界市場：透過照明、近赤外線照明、超音波技術The vein illuminator market is expected to grow at a CAGR of 32.41% between 2016 and 2022. The growth of the market is expected to be driven by the growing aging population, pediatric applications and growing demand for high patient satisfaction level. Out of the major end-user industries, market for hospitals is expected to grow at a high CAGR between 2016 and 2022 owing to the demand for technol …
- 学生情報システムの世界市場2017-2021About Student Information System SIS are highly compatible and can be installed either on a web server or local server of institutions. This encourages schools to adopt software as they will not incur high fixed cost, and they can conveniently blend traditional and online learning. Moreover, these software modules can be used via mobile devices, allowing uninterrupted information access to users. …
- 髄膜炎菌ワクチンの世界市場2016-2020About Meningitis Meningitis (meningococcal diseases) is characterized by inflammation of the protective lining (meninges) present around the brain and spinal cord. It can be classified into infectious and non-infectious meningitis. Based on the types of organism, infectious meningitis is sub-divided into bacterial meningitis, viral meningitis, fungal meningitis, and parasitic meningitis. Bacterial …
- コードレス造園機器の世界市場2019-2023About this market The continuously increasing product awareness through numerous marketing campaigns will foster the cordless garden equipment market growth during the forecast period. Campaigns against noise-generating garden equipment and growing calls for quieter alternatives will augment the market growth. Several programs are also encouraging the use of clean battery-powered lawns and garden …
- 医薬品包装機械の世界市場予測（～2023年）“The global pharmaceutical packaging equipment market is projected to grow at a CAGR of 7.4%.”The pharmaceutical packaging equipment market is expected to reach USD 8.9 billion by 2023 from an estimated USD 6.2 billion in 2018, at a CAGR of 7.4%. Growth in the generic and biopharmaceutical markets, the growing need for flexible and integrated packaging equipment, the increase in offshore pharmaceu …
